Acquisition

AcuityMD's new Salesforce integration promises to eliminate data silos and boost sales for MedTech firms, marking a strategic leap for the AI unicorn.

A new global partnership will bring simple credit card payments to thousands of EV fast chargers, tackling a key barrier to mass electric vehicle adoption.

As AI risks grow, companies like Cycore are racing to offer unified compliance solutions for a complex and costly web of new global regulations.

The research giant took a massive Q4 loss from asset impairments but points to improving client demand and a strategic overhaul as signs of a turnaround.

BOC Group launches ADONIS 18.0, leveraging AI to transform process documentation into actionable insights and bridge the gap between design and execution.

The produce giant reported strong 2025 earnings after divesting its vegetable unit, reducing debt, and investing in new high-growth areas like avocado oil.

Investment in Canadian fintech moderated to $2.4B in 2025, but a closer look reveals a healthy shift toward strategic AI and digital asset deals.

Canfor takes a $321M hit on European and pulp assets, revealing global industry woes and raising the stakes for its crucial Canfor Pulp acquisition vote.

All eyes are on Teck's Jonathan Price as he prepares to outline the company's strategy, financial health, and the future of the Anglo Teck merger.

Hecla Mining posts a record $1.4B year, slashes debt, and sells a major gold mine to double down on its strategy to dominate the North American silver market.

A new luxury community with 1-acre lots launches in Castle Rock, signaling intense demand and pitting national homebuilders against each other.

Carnelian Energy Capital funds Azul Resources II, reuniting a successful team to tap the Haynesville Shale, betting big on LNG export demand.

With strong 2025 results, packaging leader Ball Corp will address investors on its financial outlook and its central role in the sustainable materials market.

With its $6.8M acquisition of LymphaTech, Tactile Medical is integrating 3D scanning tech to revolutionize lymphedema diagnosis, treatment, and care.

As Jazz Pharmaceuticals preps for key investor talks, all eyes are on its blockbuster pipeline, revenue growth, and strategy to fend off competition.

Amid stock swings, AtlasClear uses a video series to detail its dramatic financial turnaround and strategic acquisition plans to build investor trust.

The marketplace giant reports robust GTV and adjusted earnings, but a hefty legal settlement and lower net income reveal a complex financial picture.

Paramount challenges WBD's board over its 'inferior' Netflix deal, pushing a superior $30/share all-cash offer ahead of a critical shareholder vote.

Iridium heads to key investor conferences with a message of long-term growth in PNT and direct-to-device, despite a cautious 2026 financial outlook.

Data giant SerpApi accuses a former contractor of stealing its core technology to launch a rival firm, sparking a legal war over trade secrets.